Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.
Also called NCT01819441
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,200 participants
- Sponsor
- Yining Huang
- Registry
-
NCT01819441
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01819441. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
- Acronym
- APPROVE
- Condition
- Cerebral Small Vessel Diseases
- Intervention (Drug)
- Azelnidipine
- Intervention (Drug)
- Perindopril
- Intervention (Drug)
- hydrochlorothiazide
- Lead sponsor
- Yining Huang
Record details
- Record id
cardio:ct-nct01819441- Content hash
945827127f7d8951a1a04d563cc0b4451480573b8b68c47d32586fd9ff19d130